[HTML][HTML] Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

…, W Chen, J Estrada, A Morrison-Porter… - Nature …, 2020 - nature.com
A wide spectrum of clinical manifestations has become a hallmark of the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) COVID-19 pandemic, although the …

Critically ill SARS-CoV-2 patients display lupus-like hallmarks of extrafollicular B cell activation

…, T Ozturk, S Lee, J Estrada, A Morrison-Porter… - MedRxiv, 2020 - medrxiv.org
Wide heterogeneity of disease course ranging from asymptomatic spread 1 , 2 to respiratory
failure and death 3 , 4 has become a hallmark of the SARS-CoV-2 (COVID-19) pandemic. …

[HTML][HTML] Reduced COVID-19 vaccine response in patients treated with biologic therapies for asthma

MC Runnstrom, A Morrison-Porter… - American Journal of …, 2022 - atsjournals.org
Álvarez F, Álvarez-Saa T, et al.; HiFLo-Covid Investigators. Effect of high-flow oxygen therapy
vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in …

[PDF][PDF] Dominant extrafollicular B cell responses in severe COVID-19 disease correlate with robust viral-specific antibody production but poor clinical outcomes

…, T Ozturk, S Lee, W Chen, J Estrada, A Morrison-Porter… - MedRxiv, 2020 - researchgate.net
A wide clinical spectrum has become a hallmark of the SARS-CoV-2 (COVID-19) pandemic,
although its immunologic underpinnings remain to be defined. We have performed deep …

[HTML][HTML] One-stop serum assay identifies COVID-19 disease severity and vaccination responses

…, DC Nguyen, ME Kuruvilla, A Morrison-Porter… - …, 2021 - journals.aai.org
SARS-CoV-2 has caused over 100,000,000 cases and almost 2,500,000 deaths globally.
Comprehensive assessment of the multifaceted antiviral Ab response is critical for diagnosis, …

[HTML][HTML] Delayed kinetics of IgG, but not IgA, antispike antibodies in transplant recipients following SARS-CoV-2 infection

…, NS Haddad, A Morrison-Porter… - Journal of the …, 2021 - journals.lww.com
Background Kidney transplant recipients are at increased risk of severe outcomes during
COVID-19. Antibodies against the virus are thought to offer protection, but a thorough …

Elevated SARS-CoV-2 antibodies distinguish severe disease in early COVID-19 infection

…, DC Nguyen, ME Kuruvilla, A Morrison-Porter… - BioRxiv, 2020 - biorxiv.org
Background SARS-CoV-2 has caused over 36,000,000 cases and 1,000,000 deaths globally.
Comprehensive assessment of the multifaceted anti-viral antibody response is critical for …

[HTML][HTML] Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti …

…, TTP Van, S Kyu, H Ahmed, A Morrison-Porter… - medRxiv, 2023 - ncbi.nlm.nih.gov
Novel mRNA vaccines have resulted in a reduced number of SARS-CoV-2 infections and
hospitalizations. Yet, there is a paucity of studies regarding their effectiveness on …

The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow Long-Lived Compartment 33 Months after mRNA Vaccination

DC Nguyen, IT Hentenaar, A Morrison-Porter, D Solano… - medRxiv, 2024 - medrxiv.org
The goal of any vaccine is to induce long-lived plasma cells (LLPC) to provide life-long
protection. Natural infection by influenza, measles, or mumps viruses generates bone marrow (…

The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow Long-Lived Compartment 33 Months after mRNA Vaccination

…, D Nguyen, I Hentenaar, A Morrison-Porter… - Research …, 2024 - researchsquare.com
The goal of any vaccine is to induce long-lived plasma cells (LLPC) to provide life-long
protection. Natural infection by influenza, measles, or mumps viruses generates bone marrow (…